Post-Graduation Programme in Medical Sciences, School of Medical Sciences, State University of Rio de Janeiro (UERJ), Boulevard 28 de Setembro, 77, Vila Isabel, Rio de Janeiro, 20551-030, Brazil.
Department of Pulmonology, Piquet Carneiro Policlinic, State University of Rio de Janeiro (UERJ), Avenida Mal. Rondon, 381, São Francisco Xavier, Rio de Janeiro, 20950-003, Brazil.
BMC Res Notes. 2022 May 15;15(1):176. doi: 10.1186/s13104-022-06064-6.
Exercise has been demonstrated to be beneficial for improving physical capacity and quality of life in people with scleroderma, although knowledge of its impact on the respiratory system is limited. This study evaluated the impact of therapist-oriented home rehabilitation (TOHR) on impulse oscillometry (IOS) and lung ultrasound (LUS) findings in patients with scleroderma-associated interstitial lung disease (ILD).
Twelve women with scleroderma underwent spirometry, IOS, and LUS before and after performing TOHR. Regarding spirometry, a normal pattern and restrictive damage were observed in five (41.7%) and seven (58.3%) participants pre-TOHR and post-TOHR, respectively. For IOS, an abnormal result was detected in nine (75%) pre-TOHR participants and six (50%) post-TOHR participants. Heterogeneity of resistance between 4-20 Hz (R4-R20) > 20% of the predicted value was observed in eight (66.7%) pre-TOHR participants and three (25%) post-TOHR participants (P = 0.031). An abnormal LUS result was observed in nine (75%) participants both pre-TOHR and post-TOHR. The main change observed was B-lines > 2, which was noted in nine (75%) participants both pre-TOHR and post-TOHR. Our findings suggest that TOHR for women with scleroderma-associated ILD improves the resistance and reactance measured by IOS, including small airway disease. Trial Registration ClinicalTrials.gov ID: NCT05041868 Registered on: 13th September 2021.
运动已被证明有益于改善硬皮病患者的身体能力和生活质量,但人们对其对呼吸系统的影响知之甚少。本研究评估了以治疗师为导向的家庭康复(TOHR)对硬皮病相关间质性肺病(ILD)患者脉冲震荡(IOS)和肺部超声(LUS)结果的影响。
12 名硬皮病女性患者在进行 TOHR 前后分别进行了肺量测定、IOS 和 LUS。关于肺量测定,TOHR 前有 5 名(41.7%)和 7 名(58.3%)参与者呈现正常模式和限制性损害,TOHR 后分别为 5 名(41.7%)和 7 名(58.3%)参与者呈现正常模式和限制性损害。IOS 结果异常,TOHR 前 9 名(75%)参与者和 6 名(50%)参与者TOHR 后异常。TOHR 前 8 名(66.7%)参与者和 3 名(25%)参与者的 4-20 Hz 之间的阻力异质性(R4-R20)>预测值的 20%(P=0.031)。TOHR 前 9 名(75%)参与者和 TOHR 后 9 名(75%)参与者均出现 LUS 异常结果。主要变化是 B 线>2,TOHR 前 9 名(75%)参与者和 TOHR 后 9 名(75%)参与者均出现此变化。我们的研究结果表明,TOHR 可改善硬皮病相关 ILD 女性患者 IOS 测量的阻力和电抗,包括小气道疾病。
ClinicalTrials.gov ID:NCT05041868,注册日期:2021 年 9 月 13 日。